Politics & Law
When Oversight Becomes a Market Force
House oversight activity directed at health insurer practices and alleged exchange fraud has become a sustained focus of policy and...
Read more
Refusal to File
In early 2026, the U.S. Food and Drug Administration issued a refusal-to-file letter declining to review a major manufacturer’s biologics...
Read more
The Anatomy of a Policy Reset
The 340B Drug Pricing Program — long treated as stable plumbing inside safety‑net finance — has re‑entered active policy dispute...
Read more
Women’s Health Policy Is Expanding Access Still Isn’t
The legal architecture of women’s health has been redrawn faster than the clinical delivery system can respond. Search and social...
Read moreThe Breach Is the Diagnosis: Cybersecurity Has Become a Clinical Risk Variable
The hospital can be clinically excellent, financially solvent, and fully accredited — and still be one phishing email away from...
Read more
Data Governance Is Becoming the True AI Bottleneck
Data access is negotiated, not assumed Healthcare founders often treat data access as a partnership benefit. Institutions treat it as...
Read more
Reimbursement Friction Is Steering Innovation Pathways
Coding is the first gate, not the last Without a billing code, revenue attribution is difficult. Without revenue attribution, purchasing...
Read more
Governance, Not Genius, Will Decide Whether Medical AI Helps Patients
The most dangerous myth about medical artificial intelligence is that the decisive variable is intelligence. The decisive variable is governance:...
Read more
Telemedicine Is No Longer a Pandemic Exception. It Is a Negotiation.
Telemedicine is now ordinary, which is precisely why it has become political. Patients schedule video visits with the same casual...
Read more
The Paper Trail Problem: LLMs, Clinical Care, and the Coming Reckoning in Legal Liability
The future lawsuit will be built from metadata The most consequential question about LLMs in healthcare is not whether they...
Read more
When Nutrition Becomes Federal Policy
A federal nutrition campaign rarely announces itself with quiet ambition, yet the Eat Real Food initiative does precisely that by...
Read more
Telehealth Coverage Act of 2025 Drops in Congress: Lobbying Battles Ahead of the Policy Cliff
A single paragraph in statute can determine whether a rural patient logs on or falls off the care grid. On...
Read more
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more